Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study
机构:[1]Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.[2]Department of Breast Disease, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450008, China.河南省肿瘤医院[3]Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.[4]Surgical Oncology Department, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, China.中国医科大学附属盛京医院中国医科大学盛京医院[5]Department of Breast Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.浙江省肿瘤医院[6]Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 052360, China.河北医科大学第四医院[7]Fourth Department of Breast Surgery, Jilin Cancer Hospital, Changchun, Jilin 130012, China.[8]Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.[9]Department of Breast Surgery, Affiliated Wudang Hospital of Guizhou Medical University, Guiyang, Guizhou 550009, China.[10]Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.[11]Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250033, China.[12]Breast Disease Center, Peking University First Hospital, Beijing 100034, China.[13]Department of Breast Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.浙江大学医学院附属第一医院[14]Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100852, China.[15]Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.北京朝阳医院[16]Department of Breast Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.[17]Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China.[18]Department of Thyroid, Breast, Hernia Surgery, The Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia Autonomous Region 010017, China.[19]Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200433, China.[20]Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu 730000, China.[21]Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110002, China.
第一作者机构:[1]Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
通讯作者:
通讯机构:[1]Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.[*1]Department of Breast Surgery, General SurgeryCenter, The First Affiliated Hospital of Jilin University, 71 Xinmin Street, Changchun,Jilin 130021, China
推荐引用方式(GB/T 7714):
Le Ma,Pin Gao,Zhenzhen Liu,et al.Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study[J].Chinese Medical Journal.2024,137(11):1369-1371.doi:10.1097/CM9.0000000000002849.
APA:
Le Ma,Pin Gao,Zhenzhen Liu,Dechuang Jiao,Rui Ling...&Zhimin Fan.(2024).Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study.Chinese Medical Journal,137,(11)
MLA:
Le Ma,et al."Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study".Chinese Medical Journal 137..11(2024):1369-1371